Video
Is there an opportunity before the ACCC weighs in?
Stocks
Despite advancing from its October low, the undervalued stock of this narrow-moat company may have more room to run.
Stocks
We still believe this turnaround play is an attractive opportunity after the CEO resigns amid industry challenges.
Stocks
Progress in productivity program establishes the foundation for earnings growth.
Stocks
Profit is up and the dividend was increased 29% in the latest earnings release.
Stocks
How our analyst views the shares after the clinical trial set-back.
Stocks
Shares rose after strong earnings report but remain materially undervalued.
Stocks
Our analyst weighs in on the proposed acquisition and Sigma’s capital raise.
Video
The potential for weight loss drugs to impact the sleep apnea giant has weighed on the share price, though Morningstar analyst Shane Ponraj thinks...
Stocks
Shares in the ASX giant were sold off on Wednesday as currency headwinds weigh on CSL's near-term margin recovery, but we believe the long-term...
of 2
Viewing 1 to 10 of 12